These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21084041)

  • 41. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of Medication Package Inserts in Iran.
    Khamas SS; Jafari A; Zarif-Yeganeh M; Taghvaye-Masoumi H
    J Res Pharm Pract; 2019; 8(2):45-51. PubMed ID: 31367638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of clinical pharmacists as perceived by Egyptian physicians.
    Sabry NA; Farid SF
    Int J Pharm Pract; 2014 Oct; 22(5):354-9. PubMed ID: 24467490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.
    O'Callaghan J; Bermingham M; Leonard M; Hallinan F; Morris JM; Moore U; Griffin BT
    Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review.
    Lotfi T; Morsi RZ; Rajabbik MH; Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Akl EA
    BMC Health Serv Res; 2016 Feb; 16():57. PubMed ID: 26883210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse-drug-event data provided by pharmaceutical companies.
    Cudny ME; Graham AS
    Am J Health Syst Pharm; 2008 Jun; 65(11):1071-5. PubMed ID: 18499882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Benefits and usability of a pharmaceutical record in medical practice. A survey of hospital doctors and pharmacists (MATRIX study)].
    Schuers M; Timsit M; Gillibert A; Fred A; Griffon N; Bénichou J; Darmoni SJ; Staccini P
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):229-36. PubMed ID: 27592034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Needs and Resources of Drug Information at Community Pharmacies in Gondar Town, Northwest Ethiopia.
    Asmelashe Gelayee D; Binega Mekonnen G; Birarra MK
    Biomed Res Int; 2017; 2017():8310636. PubMed ID: 28951876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacists voice their concern over patient package inserts.
    Koncel JA
    Hospitals; 1978 Jul; 52(14):103-4, 106. PubMed ID: 658918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patients' ability to read and understand dosing instructions of their own medicines - a cross sectional study in a hospital and community pharmacy setting.
    Manchanayake MGCA; Bandara GRWSK; Samaranayake NR
    BMC Health Serv Res; 2018 Jun; 18(1):425. PubMed ID: 29879961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients.
    Stebbins MR; Frear ME; Cutler TW; Lightwood JM; Fingado AR; Lai CJ; Lipton HL
    J Manag Care Pharm; 2013 Sep; 19(7):534-41. PubMed ID: 23964614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health professionals: how do they assess new medicines?
    Cheng R; Cook K; Dowman S; Lawn R; Leary J; Quinn T; Schroder K; Smith N; Tordoff J
    Pharm World Sci; 2005 Jun; 27(3):236-42. PubMed ID: 16096894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perception of pharmacists regarding over-the-counter medication: A survey.
    Ravichandran A; Basavareddy A
    Indian J Pharmacol; 2016; 48(6):729-732. PubMed ID: 28066116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacists' perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China.
    Fang Y; Yang S; Feng B; Ni Y; Zhang K
    Health Soc Care Community; 2011 Mar; 19(2):189-97. PubMed ID: 20880089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacists and patients feedback on empirically designed prescription warning labels: a qualitative study.
    Shiyanbola OO; Smith PD; Huang YM; Mansukhani SG
    Int J Clin Pharm; 2017 Feb; 39(1):187-195. PubMed ID: 28070688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adherence to oral anticancer agents: Healthcare providers' perceptions, beliefs and shared decision making in Belgium and the Netherlands.
    Verbrugghe M; Timmers L; Boons CC; Van Den Bemt BJ; Hugtenburg JG; Van Hecke A
    Acta Oncol; 2016; 55(4):437-43. PubMed ID: 26959410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied.
    Kheir N; Awaisu A; Gad H; Elazzazy S; Jibril F; Gajam M
    Int J Clin Pharm; 2015 Dec; 37(6):1180-7. PubMed ID: 26337835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
    Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
    J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.